From bench to bedside: immunotherapy for prostate cancer - Wikidata - awgldk - TriplyDB

From bench to bedside: immunotherapy for prostate cancer

From bench to bedside: immunotherapy for prostate cancer

http://www.wikidata.org/entity/Q26864390

about

A Perspective of Immunotherapy for Prostate Cancer The immunohistochemical analysis of membrane-bound CD55, CD59 and fluid-phase FH and FH-like complement inhibitors in cancers of ovary and corpus uteri origin.The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells.Immunotherapeutic advancements for glioblastoma.Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis.Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer.

P2860

Q26741277-0ACAA66A-7F78-4E10-8417-F2A04624CC1C Q36305634-2AD19781-13D8-49CF-B3F4-A23C0D52BC81 Q37065525-1EEDFDC0-C636-4B87-A515-49FD53D3C00C Q38358124-09F824C5-E199-4078-80D5-BFFF87107413 Q38699173-5CAC24A4-F2EC-48CB-B709-5AA242048FB9 Q38862880-8EFA789B-3E0D-47F5-961D-0D19237022F6 Q39093352-E569D74A-DEBE-46E8-96FA-421B16FAB046 Q41573500-EF576CE1-E147-43A4-A498-FA0A0AA23F03

P2860

From bench to bedside: immunotherapy for prostate cancer

http://www.wikidata.org/entity/Q26864390

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

From bench to bedside: immunotherapy for prostate cancer

@ast

From bench to bedside: immunotherapy for prostate cancer

@en

From bench to bedside: immunotherapy for prostate cancer

@nl

type

label

From bench to bedside: immunotherapy for prostate cancer

@ast

From bench to bedside: immunotherapy for prostate cancer

@en

From bench to bedside: immunotherapy for prostate cancer

@nl

prefLabel

From bench to bedside: immunotherapy for prostate cancer

@ast

From bench to bedside: immunotherapy for prostate cancer

@en

From bench to bedside: immunotherapy for prostate cancer

@nl

P1433

Q26864390-69F3D7DB-3DEE-41D6-80FA-9C1F2EB68208

P1476

Q26864390-C79EE28E-89CE-4989-B938-0BA9F8E0B794

P2093

Q26864390-377BF749-157C-4C4F-8BDD-4B31CE46D93C

Q26864390-3944A076-2948-4DEA-A787-7DD8CD7F6654

Q26864390-409CD766-4415-4112-A97A-E92DBFDEB4AC

Q26864390-78C2A534-48A5-433F-8B95-578FEB78B62D

Q26864390-8DD3F3AB-3D45-4DD7-848C-6800F752360C

P275

Q26864390-1390D3AA-F5BE-49E7-9BAE-219ACF5D2AED

P2860

Q26864390-0007F0D7-F151-405B-90AB-EBD67ACCACBB

Q26864390-03DA556B-7035-4D55-950A-273746E87FA9

Q26864390-0591B1D4-66E1-4A94-822F-A8EAA7B749D3

Q26864390-0FFCF75A-747C-48A2-B1B9-6968732E6FB1

Q26864390-11CEC245-5A54-45DF-BF2B-66AC4B0DC0E3

Q26864390-187759E5-256E-4147-8CBA-2E8D32C5C197

Q26864390-1EA97F87-42AB-4746-B2CD-08B4B15712F3

Q26864390-1FFCEF62-8ED0-46A7-B426-158D15C0649C

Q26864390-2188602F-8AE6-4B0F-BDE5-F7B17A03693A

Q26864390-24684328-7918-469D-8274-3F50E5968B1E

P304

Q26864390-CB2F28EA-6077-44FC-9670-5D6731263361

P31

Q26864390-603D214A-D10D-4917-8892-34F29DBEE01F

Q26864390-956742AF-FDD2-44DA-954D-F52E31237B10

P3181

Q26864390-8CB2FB38-1FA2-4714-A4AC-66DDA6F19260

P356

Q26864390-7B251C3B-3C60-4854-8717-CE89C907B728

P407

Q26864390-06079062-CDFC-4F7B-8FED-BA48EB34A743

P478

Q26864390-59FB1CB4-7714-4F15-A3C2-3DF44276F209

P50

Q26864390-70AC829A-D09C-4D19-B5A8-77992D774543

P5008

Q26864390-CAA37166-378D-4C73-A8D4-2A8C96E65289

P577

Q26864390-1A70B97A-AB73-47CB-9F10-0438D0F0C6A5

Q26864390-42A691E5-4573-466F-AB4A-4BFE9BB290D4

P5875

Q26864390-20F1B431-9D05-41DF-BE5F-7C3F14EB1CF6

P698

Q26864390-71FA2945-5A3E-4BF8-8108-604C19429A6A

P921

Q26864390-1AF3F78A-98D4-4129-AD97-93D7202C25C0

Q26864390-2433593D-F2FF-4B83-BF25-0ED78A1CBA5F

P932

Q26864390-CE309A8E-2C7F-4D40-9BDB-3C912877F868

P3181

P356

P1433

BioMed Research International

P1476

From bench to bedside: immunotherapy for prostate cancer

@en

P2093

Brian Wan-Chi Tse

http://www.w3.org/2001/XMLSchema#string

Carl Andrew Power

http://www.w3.org/2001/XMLSchema#string

Colleen Coyne Nelson

http://www.w3.org/2001/XMLSchema#string

Lidija Jovanovic

http://www.w3.org/2001/XMLSchema#string

Paul de Souza

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Global cancer statistics

New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer

A phase I trial of pox PSA vaccines (PROSTVAC-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM) in patients with prostate cancer

Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer

Combining immunological and androgen-directed approaches: an emerging concept in prostate cancer immunotherapy

Immunotherapy for prostate cancer: recent developments and future challenges

Molecular mechanisms of T cell co-stimulation and co-inhibition

Antibody-based immunotherapy for ovarian cancer: where are we at?

P304

981434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

407137

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2014/981434

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266210015

http://www.w3.org/2001/XMLSchema#string

P698

25276838

http://www.w3.org/2001/XMLSchema#string

P921

prostate cancer

P932

4168152

http://www.w3.org/2001/XMLSchema#string